Hookipa Pharma Inc (NASDAQ:HOOK – Get Free Report) saw a significant decrease in short interest in the month of February. As of February 28th, there was short interest totalling 66,200 shares, a decrease of 21.3% from the February 13th total of 84,100 shares. Based on an average daily volume of 122,100 shares, the short-interest ratio is currently 0.5 days. Approximately 1.0% of the company’s shares are short sold.
Analyst Upgrades and Downgrades
A number of analysts have recently weighed in on the stock. JMP Securities dropped their target price on shares of Hookipa Pharma from $24.00 to $7.00 and set a “market outperform” rating for the company in a report on Thursday, November 21st. Royal Bank of Canada lowered shares of Hookipa Pharma from an “outperform” rating to a “sector perform” rating and dropped their target price for the stock from $48.00 to $2.00 in a report on Friday, December 20th. Finally, HC Wainwright reiterated a “neutral” rating on shares of Hookipa Pharma in a report on Friday, January 10th.
Check Out Our Latest Stock Report on Hookipa Pharma
Hedge Funds Weigh In On Hookipa Pharma
Hookipa Pharma Price Performance
HOOK stock traded up $0.02 during trading on Monday, reaching $1.19. The company had a trading volume of 18,340 shares, compared to its average volume of 74,538. Hookipa Pharma has a 52 week low of $1.11 and a 52 week high of $10.50. The company has a market cap of $14.35 million, a P/E ratio of -0.32 and a beta of 0.71. The business has a 50 day moving average of $1.75 and a 200 day moving average of $2.86.
Hookipa Pharma Company Profile
HOOKIPA Pharma Inc, a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors.
Read More
- Five stocks we like better than Hookipa Pharma
- What Are the U.K. Market Holidays? How to Invest and Trade
- Can TikTok Stock Picks Really Make You Rich?
- 3 Small Caps With Big Return Potential
- The “Quality” Rotation: Back to Basics Investing
- How to invest in marijuana stocks in 7 stepsĀ
- Occidental Petroleum: 4 Reasons to Love These Prices
Receive News & Ratings for Hookipa Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hookipa Pharma and related companies with MarketBeat.com's FREE daily email newsletter.